{"schemaVersion":"peptidescanner-clinical-trials-history-bundle/v1","canonicalUrl":"https://peptidescanner.com/clinical-trials-history/v1/peptides/maridebart-cafraglutide.json","manifestUrl":"https://peptidescanner.com/clinical-trials-history/v1/manifest.json","peptideSlug":"maridebart-cafraglutide","addressing":"objects is keyed by the lower-case NCT number. A URL fragment #<nct number> on this file names one trial's history object.","objectCount":9,"objects":{"nct06987695":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT06987695","recordId":"NCT06987695","peptideSlug":"maridebart-cafraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06987695-maridebart-cafraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/maridebart-cafraglutide.json#nct06987695","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/maridebart-cafraglutide.md#nct06987695"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2025-05-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-05-15","publishedAt":"2026-08-23","recordId":"NCT06987695","recordSha256":"fdd4baf96a2b8461e8923e892187435c231eaa3a49dda9b8a55cf3ae17b94ddb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06987695?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2025-06-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-06-24","publishedAt":"2026-08-23","recordId":"NCT06987695","recordSha256":"9cd15a5865cc629ee67b01273b406c6ae39567be1dc089c3ca8b29d9d1f88e5c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06987695?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2025-07-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-07-16","publishedAt":"2026-08-23","recordId":"NCT06987695","recordSha256":"dd5bd62d8711cd3e1684ae882690f4901763d3ee3e6bbdd1d39b4756196f44cf","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06987695?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2025-07-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-07-30","publishedAt":"2026-08-23","recordId":"NCT06987695","recordSha256":"0acb79ba726dd6c041dbb250c0afaea2d6a33cf2fb8db1ac2c29e6448d66ad31","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06987695?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2025-08-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-08-06","publishedAt":"2026-08-23","recordId":"NCT06987695","recordSha256":"fdb33c501630c80468ad359ef69d394d53033ec86dd380502ada13ee248cede0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06987695?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Identification","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2025-11-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-11-03","publishedAt":"2026-08-23","recordId":"NCT06987695","recordSha256":"879f9a794da69fdb97a37e51ca9e30e92be312ccb3dbede7f834f1734fd4ac47","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06987695?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2025-12-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-12-15","publishedAt":"2026-08-23","recordId":"NCT06987695","recordSha256":"5eb5df8a30346abc51fe20dd9a7788a801ac71622aec2c2f4b531a416586fe7e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06987695?a=7&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"73f24d05392035001fb8c109cf3e3658ce5c909a88108d5e728b271f90809d9f"}},"nct07037433":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT07037433","recordId":"NCT07037433","peptideSlug":"maridebart-cafraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07037433-maridebart-cafraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/maridebart-cafraglutide.json#nct07037433","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/maridebart-cafraglutide.md#nct07037433"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2025-06-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-06-16","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"5098ac8d775597d71d55c58505fb31100267bda9c7620067d50dd747115c1664","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2025-07-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-07-18","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"2be3f28f0a18187bdb7159c3124f7039a6af926094025a3a949beefc8aa0354a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2025-07-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-07-24","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"22860f23d16dc8ae8312a463faf92d3250110d7b6a03a6275f19bf8f1563d50c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2025-08-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-08-06","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"9c2b406483d51331096afcde64eb8547f39f905c676d9e04388b21de8f32a149","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2025-08-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-08-13","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"ea1d65bdc29c0c20f6f2136daac7794d7293d65a999e752687dd68d6f167c682","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2025-08-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-08-27","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"7793d29451e832daaabf4d80174ff8d2ad96d9b9c62d2e33a7f87175fb1bd1ef","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2025-09-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-09-03","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"d4a4b677405d58bef2b2175d325196290fbc383278ca93685909b232e9602f11","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2025-09-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-09-10","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"6aff043c72687935883c0b21b152f4147eafe1c9eb7bb380164cf8251634ced3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2025-09-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-09-17","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"b55b9938b01df9a5a3005e4602e25d0cf1742b247f5de1a3a478193a23399677","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2025-09-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-09-24","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"4d10b44aca9c6197c0e654c965473335408464b8ca6f08b64580f7278fbb2ff5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2025-10-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-10-07","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"33671c4fd9be5456f725e854bdbc37a45da69cb7eb62e4886ccb36887bdefe3a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2025-11-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-11-01","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"828578ead71f9cf96d7acefa4dea903f1bde027f6136313f08eae5cbdd911863","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2025-11-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-11-12","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"98b418299d58528be38d0278097fe202b9f5de62a6fec2f834bd7304be016d51","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2025-12-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-12-31","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"1441d5e00106c08545a1d66dca3e9772c2742dbe42f659e239fefce47f84e8e1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2026-01-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-01-21","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"acb40e6908c2a12e470d38b1e30b3eb36181d517a4dc2cf96303592bf8c29c61","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2026-01-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-01-28","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"e7d4a14e066891e527c00a262768f6bc48b3ce22ca55b0868531748f475023a5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2026-02-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-02-11","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"1c3471f32666d604fc762c6a9c4eb440af83c0abce2ea4184d2f474b8655acd8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","IPDSharing","Outcome Measures","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2026-03-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-03-24","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"ca7b52b1a376ff47e72820bfde4ed4bc7bb908f9025ba7ef613462c65f1571d2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2026-04-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-17","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"a704a0ffa71a8ed64bbd9226744452a66b3c69b4d26ac18e511a8875eb335b02","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=19&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2026-04-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-22","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"d8cb206edc879b1110ad1940c84a3f365a0ef98eb93e4baf65eced02fcbb12fe","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=20&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":21,"lastUpdateSubmitQcDate":"2026-05-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-07","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"83c0b2a861722802cbe4547bdd91fca1a557cf18e50af3156c30fd41322e439c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=21&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":22,"lastUpdateSubmitQcDate":"2026-05-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-13","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"9b5083aa0ee7ab86e574068050a5315d9ffeeb6fba449604288da128f4978235","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=22&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":23,"lastUpdateSubmitQcDate":"2026-05-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-20","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"18ab552bad7e70788dc5c402e0b58d08e391c826c095872eefce9664a812ebc6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=23&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":24,"lastUpdateSubmitQcDate":"2026-05-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-27","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"03d819968bc3f9755c999147d7585263a2744d74e9a3a68633430aca0b153a46","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=24&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":25,"lastUpdateSubmitQcDate":"2026-06-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-06-17","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"1bc64f8e8577771a3763f684b97d617b08b70983d77a3a7c9f98cc1f84c9665d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=25&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":26,"lastUpdateSubmitQcDate":"2026-07-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-07-09","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"59a2d6373504cca097e5a7f66668aed83f67c5ee3975eb280eaf2f7df4d41933","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=26&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":27,"lastUpdateSubmitQcDate":"2026-07-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-07-22","publishedAt":"2026-08-23","recordId":"NCT07037433","recordSha256":"18ce3982feb784a548e06f0ba4dff7dc80161956489eb5b25918dd14ab579708","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037433?a=27&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"be3fb976257ea4f21cc7a47936f66e8c5176322ad8481a1efc07b5528eb7addc"}},"nct07037459":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT07037459","recordId":"NCT07037459","peptideSlug":"maridebart-cafraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07037459-maridebart-cafraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/maridebart-cafraglutide.json#nct07037459","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/maridebart-cafraglutide.md#nct07037459"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2025-06-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-06-16","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"e27cfa461c8e42b9f8513cdffdb56c1cc60c1106581f6cec4e650018c5af98b4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2025-07-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-07-10","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"d6ec36f53a47a4f28c3f18b3e761d61c1e6f06a29f83d388cd01065cd1dba693","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2025-07-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-07-24","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"16fceebdddacbdc0aaffa3ef500df03de2262be60d292cf61a786d87a700d6a8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2025-07-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-07-30","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"633c620b4fab4b8faf8220db998fbda0f0a46e1c694fcdeae6342f88356af190","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2025-08-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-08-13","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"9c4deed4551fd3dbc998ff070885cdeca28a7e0e51aa9d677264f85b6a069ca3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2025-09-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-09-03","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"374d288f6a9eb380cdc092011dcaada37cf84f6662b8eb2bbead23755bd46111","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2025-09-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-09-10","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"63e39feb2d561a615887bcc046b40fc92b124fa1a1f72bd6cdfae2af984a780d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2025-09-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-09-17","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"9177abf3ff29a1305987076da42b417e941f943f466e164df31917da5cdff3a1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2025-09-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-09-24","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"0d517f212bedeedce94d2600da739a62123381bf94a76644a4cd80d02741eb14","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2025-10-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-10-06","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"57a95aac3300f7e1635ebeb22c262ac251ad1b10dfaaa687a33791e690b6abea","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2025-10-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-10-22","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"8a63e7e23574875a5236cb13dfbd489a2348578ae92285dc6cf346fa1c42ab1a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2025-10-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-10-29","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"038946bc8f911e12321c7709b156ce795a9132f3edf0b6240890edafe9b1b52a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2025-11-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-11-12","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"98dccb0d1150274428737ac1455c9372831768acb3f0625951fad7b30ddb0eb1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2025-12-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-12-31","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"34d2db7472f5d991bc83fe315b44a8b02a596131ec9ff42ec092e7ac22d70f1e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2026-01-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-01-07","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"f0d9cec39bd2d9d442afdd1aabed159584b4555c720d9693db7bc7a3e61c9109","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","IPDSharing","Outcome Measures","Study Description","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2026-01-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-01-16","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"4e24d43bd8935c5c368c822878068601ccda0db90fda2313330b52f8f1555701","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2026-01-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-01-21","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"4370768ca9f9e6e76e0768cee831a89a974eef8b64c22a94012bc833fced30a0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2026-01-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-01-28","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"5160f5b03f82f3add11f945485d62b75600dc133fc4d7570e2d8ce4ed2f415ab","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2026-02-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-02-04","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"8a9b696b38b80e23c5ca20c21fb36982e74c845d192e95dcc012c0666347228b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=19&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2026-02-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-02-11","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"fa9e779a6c0f0df0a2bd044bc62aff483e9bc2452f8b41a229c544dafac273f5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=20&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":21,"lastUpdateSubmitQcDate":"2026-02-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-02-18","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"8d145fd6693357e0b02bd2ebf77403a5edee2b3bbb01ee93b5f35cfa5c25faf4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=21&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":22,"lastUpdateSubmitQcDate":"2026-02-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-02-25","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"1b19e1db01a8b3484553d0b967cc1033778a3a6e374719b556342a067d979dc4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=22&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":23,"lastUpdateSubmitQcDate":"2026-03-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-03-27","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"e46c16da25120d299692a8fe38f1cb7f706046875fffba786e7e200fd39edacc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=23&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":24,"lastUpdateSubmitQcDate":"2026-04-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-01","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"9295660d496d6085d5a1595fabe00a0721ef0f130cd47bb94bf73bde9ceed356","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=24&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":25,"lastUpdateSubmitQcDate":"2026-04-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-15","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"b02059f54e4bb0d2bb9dca640ee2df4dfe70547be49ca41c91a24850c7b1a64f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=25&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":26,"lastUpdateSubmitQcDate":"2026-04-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-22","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"6fc90f2925accc6a53e063139601cac05aa27017fa1c768467c0d21e51cc3ecb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=26&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":27,"lastUpdateSubmitQcDate":"2026-05-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-04","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"1cff436d0f3f35334a7f57c516aaef151329816cdac76e17a1324b634156f80c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=27&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":28,"lastUpdateSubmitQcDate":"2026-05-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-13","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"977133c74f2216e79a4bbb392917af74745ff066c4d37e899819ce491434d1df","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=28&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":29,"lastUpdateSubmitQcDate":"2026-05-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-20","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"fc4d001ace5296a99c43524bb3366e3cfbfdf518279d77344b91f95df7d47950","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=29&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Outcome Measures","Study Status"],"historyVersion":30,"lastUpdateSubmitQcDate":"2026-06-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-06-30","publishedAt":"2026-08-23","recordId":"NCT07037459","recordSha256":"a7ba1af7f6127b864da89815e44a8b41d8d7f107625a3ed9d556be965e5eae97","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07037459?a=30&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"77b27ba97f7df98ba91274b513eb3d93d789d2fc7e10b80d7a0700e8d5dbc08f"}},"nct07225686":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT07225686","recordId":"NCT07225686","peptideSlug":"maridebart-cafraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07225686-maridebart-cafraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/maridebart-cafraglutide.json#nct07225686","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/maridebart-cafraglutide.md#nct07225686"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2025-11-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-11-05","publishedAt":"2026-08-23","recordId":"NCT07225686","recordSha256":"1b18622c9299c37be7b58f3e5a5c78a0368a9c2b7e945c088aced23357d7991d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07225686?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2025-12-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-12-04","publishedAt":"2026-08-23","recordId":"NCT07225686","recordSha256":"e42fdb65fd86ddace1dec93bc1e3ddfa07479c4a2c400d4e0a971ff807a7568b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07225686?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2026-01-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-01-06","publishedAt":"2026-08-23","recordId":"NCT07225686","recordSha256":"2301c1b0831b7e69dd32921703f67a4e3f9fd3829183d9eee18d9f25bebe4d12","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07225686?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2026-01-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-01-14","publishedAt":"2026-08-23","recordId":"NCT07225686","recordSha256":"aa50a8df6e7b7199e3eabfe7dad2327c671a9afd0d706e1ffef66ec81c721bd8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07225686?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2026-01-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-01-28","publishedAt":"2026-08-23","recordId":"NCT07225686","recordSha256":"c6d4db67924bd8ceb392c741fa4816e76bc715ba49d765d639d0d5c03c44dcf0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07225686?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2026-02-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-02-04","publishedAt":"2026-08-23","recordId":"NCT07225686","recordSha256":"39edebdaa0b30066822d7ee7a0ffb03615206a0c87fe07de97a1cab000331902","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07225686?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2026-02-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-02-18","publishedAt":"2026-08-23","recordId":"NCT07225686","recordSha256":"6aa357da1b5916cc6f4a3ddccb78e5827b691a3a0f2585a51ea9e5f144509d64","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07225686?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2026-02-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-02-25","publishedAt":"2026-08-23","recordId":"NCT07225686","recordSha256":"c1532801f21e3c4b845b617c22855896af65c458c110aba061fa02a15a2e04fa","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07225686?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2026-03-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-03-04","publishedAt":"2026-08-23","recordId":"NCT07225686","recordSha256":"2ad2df9bef1a1fadf60b08bfff785925ac43e49960101a54f00a4a358dc21e5e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07225686?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2026-03-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-03-27","publishedAt":"2026-08-23","recordId":"NCT07225686","recordSha256":"97d5f70f6c18a27e5bacb6bca97eb5e04748fe7402c5cfc5225b4f6526efd96f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07225686?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2026-04-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-01","publishedAt":"2026-08-23","recordId":"NCT07225686","recordSha256":"07923bd106557d042044d00ae01de4280d5e6c939da6232ee534b0cd27fe57d9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07225686?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2026-04-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-08","publishedAt":"2026-08-23","recordId":"NCT07225686","recordSha256":"484e8d9b68b28d5299752e0e58c1ad3ff739c77f3cecda6d6f9e34c014a482e6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07225686?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2026-04-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-15","publishedAt":"2026-08-23","recordId":"NCT07225686","recordSha256":"2612404bff53fca0438c74ba9dcd663c299cfd17bc11c441e3e6c8291911220b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07225686?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2026-04-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-23","publishedAt":"2026-08-23","recordId":"NCT07225686","recordSha256":"087b7ddc8d59247acb3b6467312e90776d3102ae23189c98a6024620134ca3e0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07225686?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2026-05-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-04","publishedAt":"2026-08-23","recordId":"NCT07225686","recordSha256":"8ca286ae60be4e9b5f2b70e8543e328044cb26d86336b7fcf856c495a231f561","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07225686?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2026-05-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-13","publishedAt":"2026-08-23","recordId":"NCT07225686","recordSha256":"ebf03eedd1145341222e0ce528199ee9f438572cf3db12c28c0da2f7764c719a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07225686?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2026-05-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-20","publishedAt":"2026-08-23","recordId":"NCT07225686","recordSha256":"04e5eece886cf5b3e17274b1b6817f04fe2b533a8ab434689e23ac304df45a40","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07225686?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2026-06-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-06-10","publishedAt":"2026-08-23","recordId":"NCT07225686","recordSha256":"0fed9c04b068c31604be1128ef7bb991e9039ad993e6e32d6972c0cc1c10c034","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07225686?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Outcome Measures","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2026-08-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-08-03","publishedAt":"2026-08-23","recordId":"NCT07225686","recordSha256":"1ad36453459cfefd1dd27c2e7d2e3c547339d541d312f1f6fa9fee865e62b861","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07225686?a=19&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"1a98503ba71d1b6728f4a4b8cf82df8070b42de46c8bffce38a0e69a63740240"}},"nct07226765":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT07226765","recordId":"NCT07226765","peptideSlug":"maridebart-cafraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07226765-maridebart-cafraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/maridebart-cafraglutide.json#nct07226765","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/maridebart-cafraglutide.md#nct07226765"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2025-11-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-11-06","publishedAt":"2026-08-23","recordId":"NCT07226765","recordSha256":"3116f40a91bb6021d94ddd3a7bbdf781fcde993b30bf0f4b66a0c238487badcc","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07226765?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Identification","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2025-11-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-11-19","publishedAt":"2026-08-23","recordId":"NCT07226765","recordSha256":"f591c96149765096cd6118915c863bb629c3a5a189fec5e932a0b3381ab3ca20","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07226765?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2025-12-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-12-12","publishedAt":"2026-08-23","recordId":"NCT07226765","recordSha256":"f048734a25a78f1414a3e1734a92a0c1cd4b572ef5aadec007d2c144ad01aac1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07226765?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2026-01-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-01-14","publishedAt":"2026-08-23","recordId":"NCT07226765","recordSha256":"657b22cb522b993dfb782443f7e8c0372c8531bcbffaa3f418a2bb246829e3b5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07226765?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2026-01-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-01-28","publishedAt":"2026-08-23","recordId":"NCT07226765","recordSha256":"19761ea86a18f6239e4b86980b0a62814817f952c13aa7c2e0ec5b5cb6ef265b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07226765?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2026-02-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-02-04","publishedAt":"2026-08-23","recordId":"NCT07226765","recordSha256":"7a93d52fe1abffda411b43261bb8177e54b34cb5a3e44b6f2c2b681a238dcb97","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07226765?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2026-02-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-02-11","publishedAt":"2026-08-23","recordId":"NCT07226765","recordSha256":"6193adaf3dc28d86b5c2d9d3bad7f7f58605684fe94901fb5a86b07595787218","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07226765?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2026-02-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-02-18","publishedAt":"2026-08-23","recordId":"NCT07226765","recordSha256":"c539ec5f7f1836331169be84b4f118e65d8c4b756996df2913a02cd38fe522f6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07226765?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2026-02-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-02-25","publishedAt":"2026-08-23","recordId":"NCT07226765","recordSha256":"c567860a0be5b73ca8a4a49f4099b0e4ffc0d12399d4b54d352ed491958df88f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07226765?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2026-03-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-03-04","publishedAt":"2026-08-23","recordId":"NCT07226765","recordSha256":"850aa4112c9d9ac2031d6d5d584c8a34f76b3d2a94bb4ce16e7d37492e6fba15","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07226765?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2026-03-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-03-27","publishedAt":"2026-08-23","recordId":"NCT07226765","recordSha256":"563935be9715c2edc387f954f2672ff57895792d8dbebd7ce801d60434a471eb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07226765?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2026-04-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-01","publishedAt":"2026-08-23","recordId":"NCT07226765","recordSha256":"9f88f3cb01d38f82ed322c998eead7b768ff7ac68a71cfa83464c8444a95d623","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07226765?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2026-04-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-08","publishedAt":"2026-08-23","recordId":"NCT07226765","recordSha256":"eb9939612e5c5c3191fd4aec91ce1538011ba309f18098948286b59c3fb3ea87","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07226765?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2026-04-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-15","publishedAt":"2026-08-23","recordId":"NCT07226765","recordSha256":"2d97ba371d6da2b836ed259d8e5caf721f03a7cea5132ab4ce29f16c40be3a4d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07226765?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2026-04-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-23","publishedAt":"2026-08-23","recordId":"NCT07226765","recordSha256":"dda2116414fcc545607555e48fc84af3f413e194b618494d3af516d2065b1b6b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07226765?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2026-05-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-04","publishedAt":"2026-08-23","recordId":"NCT07226765","recordSha256":"cda22e97718644ef90ce1271ab81765435763f3fe4e3ebe9f38754fb216855f4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07226765?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2026-05-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-13","publishedAt":"2026-08-23","recordId":"NCT07226765","recordSha256":"bbad7022976dccc567c8a0db3205cc75047fb3d14f02c703544be0e56b3cf59d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07226765?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2026-05-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-20","publishedAt":"2026-08-23","recordId":"NCT07226765","recordSha256":"30fdc67e8c3661715c2d2ab2b3a7a5039b1db0835cb46296ebcaa943ace482df","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07226765?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2026-06-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-06-03","publishedAt":"2026-08-23","recordId":"NCT07226765","recordSha256":"eac82203352911965b976b75877687e962cc6cc3faac2e7639fff5644868ed1c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07226765?a=19&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2026-06-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-06-10","publishedAt":"2026-08-23","recordId":"NCT07226765","recordSha256":"11011bfa58dfdafd0f3439cb97ed55313dc0247fbb60ad9a2dbc668551996d59","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07226765?a=20&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Outcome Measures","Study Status"],"historyVersion":21,"lastUpdateSubmitQcDate":"2026-08-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-08-13","publishedAt":"2026-08-23","recordId":"NCT07226765","recordSha256":"4d61fbb658ba8660ea80b66465b24d33646edb23773f2b0debdb7d4993b1bf4e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07226765?a=21&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"411df76cd2f2ec8d02bea83ac590c334d0dd6fcb90bf144c501d4a639ecf80a2"}},"nct07229157":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT07229157","recordId":"NCT07229157","peptideSlug":"maridebart-cafraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07229157-maridebart-cafraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/maridebart-cafraglutide.json#nct07229157","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/maridebart-cafraglutide.md#nct07229157"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2025-11-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-11-13","publishedAt":"2026-08-23","recordId":"NCT07229157","recordSha256":"8a7bbdf3525be5ab4d7a26641d23e28d86d72d1fa046d677854e51d3c720074c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07229157?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2025-11-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-11-25","publishedAt":"2026-08-23","recordId":"NCT07229157","recordSha256":"ae1a7ac9874058718ec3e14422c411c9053519d1fb1f9b69b297daeb0d564227","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07229157?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2025-12-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-12-10","publishedAt":"2026-08-23","recordId":"NCT07229157","recordSha256":"3c20282dda0b954b87b86425b354d8a26cf332622d73c4ae763f816424da7ca0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07229157?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2026-01-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-01-22","publishedAt":"2026-08-23","recordId":"NCT07229157","recordSha256":"87c9a1ac3699405bd8b6f18cdfdf8af84869e6b8e8c8367b48e5688d789a1070","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07229157?a=4&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"8f31029ecd9cebf410dc1aaade1541487b0fb254dee03d00444a4529b4546a7d"}},"nct07313761":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT07313761","recordId":"NCT07313761","peptideSlug":"maridebart-cafraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07313761-maridebart-cafraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/maridebart-cafraglutide.json#nct07313761","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/maridebart-cafraglutide.md#nct07313761"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2025-12-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2025-12-19","publishedAt":"2026-08-23","recordId":"NCT07313761","recordSha256":"871da0cf6b4daec213a0b649454086edcd617259bde1d9a1b1278c8febde6c83","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07313761?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2026-01-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-01-05","publishedAt":"2026-08-23","recordId":"NCT07313761","recordSha256":"67e72a68166ad82551036c3beec2b87f8b3c0381ddb337c0b209febfeeb151c9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07313761?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2026-03-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-03-18","publishedAt":"2026-08-23","recordId":"NCT07313761","recordSha256":"0a769d0d04590ae1d7d01b624e2b4ac6d930c1cce306afd9975c74a9552d1873","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07313761?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2026-07-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-07-15","publishedAt":"2026-08-23","recordId":"NCT07313761","recordSha256":"f6306be29148f350e707cde934ef360e3b66f9bf0fcdfa42c0b5074751c443f6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07313761?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2026-08-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-08-06","publishedAt":"2026-08-23","recordId":"NCT07313761","recordSha256":"857ae4fc8ae0f5ac060a55e160c24e0ab865c55ccda904acf8ca6f65fdbe7124","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07313761?a=5&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"e75a4cb13364745132cd31472395ca4e34f6390ed40a0b99d3851fb514474cd7"}},"nct07441252":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT07441252","recordId":"NCT07441252","peptideSlug":"maridebart-cafraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07441252-maridebart-cafraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/maridebart-cafraglutide.json#nct07441252","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/maridebart-cafraglutide.md#nct07441252"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2026-02-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-02-26","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"90c1925120927db244894b75f426c8aebdea34342479f5a3094372c75d8800c2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2026-03-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-03-18","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"399dea797dcea78e51cdb1e87736bc36992bb031f1e954a6c12e1389b9dd2a14","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2026-03-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-03-27","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"b59811caf54470e22e44b4dc75cdaf1302f1ee2e5c2523ce536784f34030bc7f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2026-04-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-01","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"94cab06b46244cfeb5efefba8be4c2976c1f34779276838f4afaeba059960011","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2026-04-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-08","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"1629f9006ac234cc9dd8829e3e0311536a38908e795bd1dbb39bf8311414c980","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2026-04-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-15","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"937691ba8e3b0e0c012afc0eb8ac1245852fbf3db45324e41faee09c45b6dd36","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2026-04-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-22","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"76ed9cb05f15d3bcb84fa584ff963a0f73e96fccbc86459def591d377f5ca976","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2026-05-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-04","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"d3b9d7e1ac68ad263bdde8b89a0e233d7ae22ac416694ca543b160d8d5b5ea52","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2026-05-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-20","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"368ca0e6dda9cffabd71263cab6a7d6a4a98eee717c83222dfdd6db5221437cf","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2026-06-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-06-03","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"758bdcbe34eca021845a0496bce0c940d86132ac9b4957f01fec949eb90dba6a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2026-06-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-06-17","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"7461751a197fabf6337064c3c78a8af54bd1b050322e3958adc56d6de40eddb3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=11&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"1e1cf2a99b7d44749c2550228fa46895568e576af4f73d57ffec8e843a6b0b0d"}},"nct07684235":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT07684235","recordId":"NCT07684235","peptideSlug":"maridebart-cafraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07684235-maridebart-cafraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/maridebart-cafraglutide.json#nct07684235","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/maridebart-cafraglutide.md#nct07684235"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2026-06-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-06-29","publishedAt":"2026-08-23","recordId":"NCT07684235","recordSha256":"56d7fa80e439956753e606af8c9bac024e62c658749d12345fef46e98c995dce","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07684235?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2026-08-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-08-01","publishedAt":"2026-08-23","recordId":"NCT07684235","recordSha256":"5a154c46eeda005efe2ace5226ddf73d3ddc0eb82a8b26ed8617d71e420eacc7","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07684235?a=2&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"b7703c9684e44870fe6f0f486d0a05fc60bd3e541e5980fc1d4b57b653a9a76f"}}}}
